These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 11437321)

  • 41. Arylazolylthioacetanilide. Part 8: Design, synthesis and biological evaluation of novel 2-(2-(2,4-dichlorophenyl)-2H-1,2,4-triazol-3-ylthio)-N-arylacetamides as potent HIV-1 inhibitors.
    Zhan P; Chen X; Li X; Li D; Tian Y; Chen W; Pannecouque C; De Clercq E; Liu X
    Eur J Med Chem; 2011 Oct; 46(10):5039-45. PubMed ID: 21872971
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Synthesis, anti-HIV-1 activity, and modeling studies of N-3 Boc TSAO compound.
    Tomassi C; Nguyen VN; Marco-Contelles J; Balzarini J; Pannecouque C; De Clercq E; Soriano E; Postel D
    Bioorg Med Chem Lett; 2008 Apr; 18(7):2277-81. PubMed ID: 18353641
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Synthesis and evaluation of N-aryl pyrrolidinones as novel anti-HIV-1 agents. Part 1.
    Wu B; Kuhen K; Ngoc Nguyen T; Ellis D; Anaclerio B; He X; Yang K; Karanewsky D; Yin H; Wolff K; Bieza K; Caldwell J; He Y
    Bioorg Med Chem Lett; 2006 Jul; 16(13):3430-3. PubMed ID: 16632349
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Molecular design, synthesis and biological evaluation of BP-O-DAPY and O-DAPY derivatives as non-nucleoside HIV-1 reverse transcriptase inhibitors.
    Yang S; Pannecouque C; Daelemans D; Ma XD; Liu Y; Chen FE; De Clercq E
    Eur J Med Chem; 2013 Jul; 65():134-43. PubMed ID: 23707918
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Abasic analogues of TSAO-T as the first sugar derivatives that specifically inhibit HIV-1 reverse transcriptase.
    Velázquez S; Chamorro C; Pérez-Pérez MJ; Alvarez R; Jimeno ML; Martín-Domenech A; Pérez C; Gago F; De Clercq E; Balzarini J; San-Félix A; Camarasa MJ
    J Med Chem; 1998 Nov; 41(23):4636-47. PubMed ID: 9804703
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Synthesis, anti-human immunodeficiency virus activity and esterase lability of some novel carboxylic ester-modified phosphoramidate derivatives of stavudine (d4T).
    McGuigan C; Sutton PW; Cahard D; Turner K; O'Leary G; Wang Y; Gumbleton M; De Clercq E; Balzarini J
    Antivir Chem Chemother; 1998 Nov; 9(6):473-9. PubMed ID: 9865385
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Design and synthesis of 2-(2,6-dibromophenyl)-3-heteroaryl-1,3-thiazolidin-4-ones as anti-HIV agents.
    Rawal RK; Tripathi R; Katti SB; Pannecouque C; De Clercq E
    Eur J Med Chem; 2008 Dec; 43(12):2800-6. PubMed ID: 18242784
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Discovery of 3,4-dihydropyrimidin-2(1H)-ones with inhibitory activity against HIV-1 replication.
    Kim J; Park C; Ok T; So W; Jo M; Seo M; Kim Y; Sohn JH; Park Y; Ju MK; Kim J; Han SJ; Kim TH; Cechetto J; Nam J; Sommer P; No Z
    Bioorg Med Chem Lett; 2012 Mar; 22(5):2119-24. PubMed ID: 22305583
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Synthesis, structure-activity relationships, and docking studies of N-phenylarylformamide derivatives (PAFAs) as non-nucleoside HIV reverse transcriptase inhibitors.
    Ma XD; He QQ; Zhang X; Yang SQ; Yang LM; Gu SX; Zheng YT; Chen FE; Dai HF
    Eur J Med Chem; 2012 Dec; 58():504-12. PubMed ID: 23164656
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Synthesis and anti-HIV-1 activity of novel 2,3-dihydro-7H-thiazolo[3,2-a]pyrimidin-7-ones.
    Danel K; Pedersen EB; Nielsen C
    J Med Chem; 1998 Jan; 41(2):191-8. PubMed ID: 9457243
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Isothiazole derivatives as novel HIV replication inhibitors.
    Cutrì CC; Garozzo A; Pannecouque C; Castro A; Guerrera F; De Clercq E
    Antivir Chem Chemother; 2004 Jul; 15(4):201-5. PubMed ID: 15457681
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Nitroimidazoles. V. Synthesis and anti-HIV evaluation of new 5-substituted piperazinyl-4-nitroimidazole derivatives.
    Al-Soud YA; Al-Masoudi NA; Hassan HG; De Clercq E; Pannecouque C
    Acta Pharm; 2007 Dec; 57(4):379-93. PubMed ID: 18165184
    [TBL] [Abstract][Full Text] [Related]  

  • 53. N1-Alkyl pyrimidinediones as non-nucleoside inhibitors of HIV-1 reverse transcriptase.
    Mitchell ML; Son JC; Guo H; Im YA; Cho EJ; Wang J; Hayes J; Wang M; Paul A; Lansdon EB; Chen JM; Graupe D; Rhodes G; He GX; Geleziunas R; Xu L; Kim CU
    Bioorg Med Chem Lett; 2010 Mar; 20(5):1589-92. PubMed ID: 20138513
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Synthesis and studies of new 2-(coumarin-4-yloxy)-4,6-(substituted)-S-triazine derivatives as potential anti-HIV agents.
    Mahajan DH; Pannecouque C; De Clercq E; Chikhalia KH
    Arch Pharm (Weinheim); 2009 May; 342(5):281-90. PubMed ID: 19415671
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Exploring the role of the 5'-position of TSAO-T. Synthesis and anti-HIV evaluation of novel TSAO-T derivatives.
    Chamorro C; Pérez-Pérez MJ; Rodríguez-Barrios F; Gago F; De Clercq E; Balzarini J; San-Félix A; Camarasa MJ
    Antiviral Res; 2001 Jun; 50(3):207-22. PubMed ID: 11397508
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A multidisciplinary approach for the identification of novel HIV-1 non-nucleoside reverse transcriptase inhibitors: S-DABOCs and DAVPs.
    Radi M; Falciani C; Contemori L; Petricci E; Maga G; Samuele A; Zanoli S; Terrazas M; Castria M; Togninelli A; Esté JA; Clotet-Codina I; Armand-Ugón M; Botta M
    ChemMedChem; 2008 Apr; 3(4):573-93. PubMed ID: 18081133
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Triazole derivatives as non-nucleoside inhibitors of HIV-1 reverse transcriptase--structure-activity relationships and crystallographic analysis.
    Kirschberg TA; Balakrishnan M; Huang W; Hluhanich R; Kutty N; Liclican AC; McColl DJ; Squires NH; Lansdon EB
    Bioorg Med Chem Lett; 2008 Feb; 18(3):1131-4. PubMed ID: 18083512
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Synthesis and anti-HIV activity of new alkenyldiarylmethane (ADAM) non-nucleoside reverse transcriptase inhibitors (NNRTIs) incorporating benzoxazolone and benzisoxazole rings.
    Deng BL; Cullen MD; Zhou Z; Hartman TL; Buckheit RW; Pannecouque C; De Clercq E; Fanwick PE; Cushman M
    Bioorg Med Chem; 2006 Apr; 14(7):2366-74. PubMed ID: 16321539
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Synthesis and evaluation of 2-(2,6-dihalophenyl)-3-pyrimidinyl-1,3-thiazolidin-4-one analogues as anti-HIV-1 agents.
    Rawal RK; Tripathi R; Katti SB; Pannecouque C; De Clercq E
    Bioorg Med Chem; 2007 May; 15(9):3134-42. PubMed ID: 17349793
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Synthesis of new 2,3-diaryl-1,3-thiazolidin-4-ones as anti-HIV agents.
    Rao A; Balzarini J; Carbone A; Chimirri A; De Clercq E; Monforte AM; Monforte P; Pannecouque C; Zappalà M
    Farmaco; 2004 Jan; 59(1):33-9. PubMed ID: 14751314
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.